Neal I. Lindeman - Concepedia

Author

Neal I. Lindeman

Also Known As

Alicia Crdoba, Bruce Johnson, Eva Lepisto, Lindeman, Neal, Lindeman, Neal I., Michael E Hurwitz, Monica Manam, Myers, Richard M., N Lindeman, N. I. Lindeman

474

Publications

42.6K

Citations

H-Index

133

Concepts

All Affiliations

Brigham and Women's Hospital Harvard University Dana-Farber Cancer Institute Broad Institute Massachusetts General Hospital

About

Neal I. Lindeman is an author at Brigham and Women's Hospital specializing in medicine, pathology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	39	59	9K
2	Health Sciences	7	7	1.1K
3	Engineering	5	5	700
4	Arts	1	1	71
5	Management	1	1	20

Neal I. Lindeman

144

Publications

39.5K

Citations

H-Index

Page 1

	Year	Citations
<i>EGFR</i> Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, Science	2004	9.4K
<i>MET</i> Amplification Leads to Gefitinib Resistance in Lung Cancer by Activating ERBB3 Signaling Jeffrey A. Engelman, Kreshnik Zejnullahu, Tetsuya Mitsudomi, Science	2007	4.4K
AACR Project GENIE: Powering Precision Medicine through an International Consortium Fabrice André, Mónica Arnedos, Alexander S. Baras, Cancer Discovery	2017	1.9K
Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology Neal I. Lindeman, Philip T. Cagle, Mary Beth Beasley, Journal of Thoracic Oncology	2013	1.3K
Characterizing the cancer genome in lung adenocarcinoma Barbara A. Weir, Michele Sue‐Ann Woo, Gad Getz, Nature	2007	1.1K
LKB1 modulates lung cancer differentiation and metastasis Hongbin Ji, Matthew R. Ramsey, D. Neil Hayes, Nature MedicineLung Cancer DifferentiationCancer GeneticsCancer BiologyCell Biology	2007	1.1K
Preexistence and Clonal Selection of MET Amplification in EGFR Mutant NSCLC Alexa B. Turke, Kreshnik Zejnullahu, Yi‐Long Wu, Cancer Cell Signal TransductionMet AmplificationMedicineMolecular BiologyEgfr Mutant Nsclc	2010	1.1K
<i>EML4-ALK</i> Fusion Gene and Efficacy of an ALK Kinase Inhibitor in Lung Cancer Jussi Koivunen, Craig H. Mermel, Kreshnik Zejnullahu, Clinical Cancer Research	2008	974
Acute myeloid leukemia ontogeny is defined by distinct somatic mutations R. Coleman Lindsley, Brenton G. Mar, Emanuele Mazzola, Blood	2014	960
Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors: Guideline From the College of American Pathologists, the International Association for the Study of Lung Cancer, and the Association for Molecular Pathology Neal I. Lindeman, Philip T. Cagle, Dara L. Aisner, Archives of Pathology & Laboratory Medicine	2018	887

Page 1